Skip To Content

Study ID: BMS CA209370 Checkmate 370 Lung

Title:

A Master Protocol of Phase 1/2 Studies of Nivolumab in Advanced NSCLC Using Nivolumab as Maintenance after Induction Chemotherapy or as First-line Treatment Alone or in Combination with Standard of Care Therapies (CA209370)

Location:
Sioux Falls Region
Principal Investigator:
Steven Powell, MD
Disease:
Non-Small Cell Lung Cancer
Stage:
Phase I/II
Status:
Active - Partially Closed to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.